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Abstract Air pollution has been associated with significant
adverse health effects leading to increased overall morbidity
and mortality of worldwide significance. Epidemiological
studies have shown that the largest portion of air pollution-
related mortality is due to cardiovascular diseases, predomi-
nantly those of ischemic nature. Human studies suggest an
association with atherosclerosis and increasing experimental
animal data support that this association is likely to be causal.
While both gasses and particles have been linked to
detrimental health effects, more evidence implicates the
particulate matter (PM) components as major responsible
for a large portion of the proatherogenic effects. Multiple
experimental approaches have revealed the ability of PM
components to trigger and/or enhance free radical reactions
in cells and tissues, both ex vivo as well as in vivo. It
appears that exposure to PM leads to the development of
systemic prooxidant and proinflammatory effects that may
be of great importance in the development of atheroscle-
rotic lesions. This article reviews the epidemiological
studies, experimental animal, and cellular data that support
the association of air pollutants, especially the particulate
components, with systemic oxidative stress, inflammation,
and atherosclerosis. It also reviews the use of transcriptomic
studies to elucidate molecular pathways of importance in
those systemic effects.
Keywords Air pollution.Particulate matter.Ultrafine
particles.Oxidative stress.Inflammation.Atherosclerosis.
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Exposure to air pollution is associated
with atherosclerosis
Extensive epidemiological evidence supports the associa-
tion of air pollution with adverse health effects leading to
increased morbidity and mortality of worldwide signifi-
cance (Brook et al. 2004; Bhatnagar 2006; Brook et al.
2010) mostly due to cardiovascular diseases and predom-
inantly those of ischemic character (Pope et al. 2004). Thus,
exposure to air pollution is now recognized as a novel
cardiovascular risk factor of great importance since it is
modifiable and with the potential to affect large numbers of
people around the globe. While air pollution is a complex
mixture of compounds in gaseous (ozone, CO, and nitrogen
oxides) and particle phases, the cardiovascular effects have
beenmostlyascribedtoits particulate components(Bhatnagar
2006;B r o o k2008;A r a u j oa n dN e l2009). Ambient particles
can be classified according to their aerodynamic diameter
into size fractions such as particulate matter (PM)10
(“thoracic” particles, <10 μm), PM2.5–10 (“coarse” particles,
2.5–10 μm), PM2.5 (fine particles, <2.5 μm) and ultrafine
particles (UFP, <0.1 μm; U.S.EPA 2004) that are derived
from various sources and by a variety of processes
characteristic of each size fraction. For instance, UFP are
mostly generated through tailpipe emission from mobile
sources (motor vehicles, aircrafts, etc.), while major sources
of PM2.5 include power plants, oil refinery, wildfires,
tailpipe, brake emissions from mobile sources and coarse
particles are typically derived from soil, agricultural and road
dust, construction debris, among others.
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DOI 10.1007/s11869-010-0101-8Various mechanisms have been proposed to explain how
inhalation of ambient particulate could result in systemic
cardiovascular effects such as: (1) activation of pulmonary
receptors resulting in autonomic nervous system imbalance
and the development of dysrhythmias; (2) induction of
pulmonary and systemic inflammation; (3) access of
particles or their chemical constituents to the systemic
circulation (Fig. 1). The latter two mechanisms can lead to
the induction of atherothrombotic effects responsible for
acute coronary syndromes and ischemic heart disease.
Indeed, several studies support the association between air
pollution and atherosclerosis in humans (Table 1). Kunzli et
al. reported in 2005 a cross-sectional study where the
degree of carotid intima-medial thickness (CIMT) of 798
individuals correlated with an increase of 5.9% for every
10 μg/m
3 rise in PM2.5 levels (Kunzli et al. 2005; Table 1).
A recent study on a related population also showed that the
annual rate of CIMT progression among individuals living
within 100 m of a highway was accelerated and more than
twice the population mean progression (Kunzli et al. 2010).
Likewise, Hoffman et al. (2007) reported an association
between long-term residential exposure to high traffic and
coronary artery calcification (CAC) scores as a measure of
coronary atherosclerosis. They found in a German cohort
study including 4,494 participants, that as compared with
subjects living >200 m away from a major road, subjects
living within 101–200 m, 51–100 or less than 50 m showed
8%, 34%, and 63% increase in the probability of having a
high CAC scores, respectively (Table 1). Data from the
Multi-Ethnic Study of Atherosclerosis (Diez Roux et al.
2008; Allen et al. 2009) also support the association of PM
with atherosclerosis. Diez Roux et al. (2008) reported that
PM10 exposures assessed over long-term (20-year means
and 2001 mean) and 20-yearPM2.5 exposures did correlate
with 1–3% increase in CIMT per 21 μg/m
3 increase in
PM10 or 12.5 μg/m
3 increase in PM2.5, respectively.
Likewise, Allen et al. (2009) reported that PM2.5 exposures
correlated with increased risk for aortic calcification in a
related study (Table 1).
While epidemiological studies with PM10 and PM2.5 data
support that a smaller particle size correlates with larger
cardiovascular effects, there are only few reports supporting
the association of UFP with increased total or cardio-
respiratory mortality (Wichmann et al. 2000; Yue et al.
2007) and there are no reports that support an association
between UFP and atherosclerosis yet, partly due to the
difficulty to perform reliable measurements of UFP particle
number and mass concentrations since they are very
dependent on the proximity to the source of generation.
Despite the lack of direct evidence, it has been suggested
that associations between PM and cardiovascular (CV)
morbidity and mortality could be even stronger with the
s m a l l e rp a r t i c l e s .I nas t u d yc o n d u c t e di nf o u rl a r g e
retirement communities in the Los Angeles basin, Delfino
et al. (2009) followed 60 elderly subjects with history of
CAD over 7-month periods with a very detailed pollutant
exposure characterization and blood collection for the
determination of systemic inflammatory, antioxidant and
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Fig. 1 Potential mechanisms
how exposure to PM leads to
CVdisease.Threemainpathways
could mediate PM-related cardio-
vascular effects: (1) induction of
autonomic nervous system im-
balance, (2) development of
pulmonary oxidative stress and
inflammation with systemic
“spill-over” of inflammatory
mediators (e.g., cytokines,
activated cells), (3) translocation
of particles and/or chemical
constituents to the systemic
circulation.CHF congestive heart
failure, CV cardiovascular, CVA
cerebrovascular accident, EC
endothelial cells, IHD ischemic
heart disease, PVD peripheral
vascular disease. Pulmonary
inflammation may range from
activation of inflammatory
molecular pathways without
histological evidence of it to
overt infiltration by inflammatory
cells. Taken from Araujo and
Brook (2011)
80 Air Qual Atmos Health (2011) 4:79–93coagulation markers. They found positive associations of
particle number (dominated by UFPs) and outdoor quasi-
ultrafine PM0.25 (<0.25 μm) with biomarkers of systemic
inflammation such as interleukin (IL)-6, soluble tumor
necrosis factor receptor II (sTNF-RII), and C-reactive
protein (CRP; Delfino et al. 2008, 2009). This study is in
agreement with a previous report where exposure to UFP
correlated with increased plasma levels of soluble CD40
ligand (sCD40L), a marker for platelet activation that can
cause increased coagulation and inflammation (Ruckerl et
al. 2007) as well as other repeated-measure studies showing
associations between ambient air pollution and biomarkers
of systemic inflammation in healthy young adults (Chuang
et al. 2007) and susceptible subjects with CAD (Dubowsky
et al. 2006; Ying et al. 2009b).
Role of particle size and chemical composition
The cardiovascular toxicity of particles may depend on
several physicochemical parameters that can determine
their ability to travel through the tracheobronchial tree
upon inhalation, interact with cellular components in the
lungs and either penetrate into the systemic circulation or
trigger responses in the lungs that can be transduced
systemically. Particle cardiopulmonary toxicity appears to
correlate with their prooxidant and proinflammatory poten-
tials. In this article, we mostly refer to evidence accrued
using ambient particulate matter and/or diesel exhaust
particles (DEP) as a model pollutant. Multiple studies have
demonstrated that DEP can promote the generation of
reactive oxygen species (ROS) in macrophages, bronchial
epithelial cells and lung microsomes incubated with the
particles or their organic extracts (Hiura et al. 1999; Li et al.
2002). DEP can also induce oxidative stress and cellular
effects in target vascular cells such as endothelial cells (Bai
et al. 2001; Hirano et al. 2003; Gong et al. 2007; Li et al.
2009) as indicated in more details below.
It appears that DEP redox properties reside in their polar
and aromatic fractions as they most actively induce the
expression of heme oxygenase-1 (HO-1), glutathione S-
transferase and other phase II enzymes in response to
increased oxidative stress (Li et al. 2004). This antioxidant
response is modulated by the p45-NFE2 related transcrip-
tion factor 2 (Nrf2) (Li et al. 2004), which is able to escape
proteosomal degradation in the cytoplasm and translocate to
the nucleus under the influence of electrophiles (Li et al.
2004). Ambient PM can also induce tissue oxidative stress
and trigger Nrf2-regulated antioxidant gene expression in
response to its content of prooxidative and electrophilic
chemicals that differ markedly among the various particle
sizes. Different particle sizes are apparently married to
different chemical compositions resulting in different proox-
idant and proatherosclerotic effects as it is described below.
Thus, UFP collectedfromvarious locations andseasons differ
significantly in their ability to trigger Nrf2-regulated
responses, in strong relationship with their chemical compo-
sition (e.g., content of polycyclic aromatic hydrocarbons;
PAHs) and prooxidant potential (Li et al. 2003).
Of even larger importance to the data generated by in
vitro approaches, it is the fact that several studies have
demonstrated the ability of PM to promote systemic
prooxidant and proinflammatory effects in vivo as well as
enhanced atherosclerotic lesion development. This body of
evidence not only confirms the relevance of the in vitro
data but also brings support to the notion that the particle
prooxidative and proinflammatory potentials may be
important determinants of particle vascular toxicity. Table 2
summarizes several of those studies that support the causal
association between particulate air pollution and athero-
sclerosis using various animal models. Exposures to air
pollutants have been performed via intratracheal instillations
Table 1 Human studies linking exposure to air pollution with atherosclerosis
Study Air pollutant Evaluation of
atherosclerosis
Major findings Reference
Kunzli et al. 2005 PM2.5-Ozone CIMT 5.9% increased in CIMT per every
10 μgPM2.5/m
3
(Kunzli et al. 2005)
Hoffmann et al. 2007 PM2.5-Distance to
major road
CACS Increased CAC scores with shorter distances
to a major road
(Hoffmann et al. 2007)
Diez Roux et al. 2008 PM10-PM2.5 CIMT CACS BAI 1–3% increase in CIMT per every increase in
21 and 12.5 μg/m
3 of PM10 and PM2.5 respectively
(Diez Roux et al. 2008)
Allen et al. 2009 PM2.5-distance to
major road
Aortic calcification 6% increase in the risk of aortic calcification
with a 10 μg/m
3 increase in PM2.5
(Allen et al. 2009)
Hoffman et al. 2009 PM2.5-distance to
major road
BAI Decreased BAI in subjects living within
50 meters from a major road, especially women
(Hoffman et al. 2009)
Kunzli et al. 2010 PM2.5-distance to
highway or major
road
CIMT Greater annual progression of CIMT among
individuals living <100 m from a highway
(Kunzli et al. 2010)
Studies are listed in chronological order based on the year of publication. CIMT carotid intima-media thickness, CACS coronary artery calcium
score, BAI brachial artery index. Modified from Araujo (2011)
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82 Air Qual Atmos Health (2011) 4:79–93(IT) of PM as well as inhalation of polluted air, concentrated
ambient particles (CAPs), or diesel exhaust emissions. These
various exposure modalities differ in their degree of difficulty
and their ability to model “real life” scenarios. Thus, while IT
inhalations can be manipulated experimentally at ease, they
may be more limited to reflect physiologically relevant
exposures. On the other hand, inhalation of CAPs can model
physiological conditions better but are more difficult to be
conducted. Importantly, the convergence of similar findings
derived from different exposure modalities helps in data
interpretation and brings robustness to the conclusions
derived.
Indeed, IT PM10 and IT carbon black have been reported
to stimulate atherosclerotic lesion formation in Watanabe
hyperlipidemic rabbits (Suwa et al. 2002; Yatera et al.
2008) and low-density lipoprotein-receptor (LDL-R)
−/−
mice (Niwa et al. 2007), respectively. In those studies,
atherosclerosis was assessed both in the coronary arteries
(Suwa et al. 2002) and in the aorta (Suwa et al. 2002; Niwa
et al. 2007; Yatera et al. 2008). On the other hand, the effect
of PM2.5 has been mostly evaluated by long-term inhalation
exposures to concentrated PM2.5. Five studies have been
reported where concentrated PM2.5 led to enhanced
atherosclerosis in apoE null mice exposed to CAPs at
Sterling Forest, New York (Chen et al. 2010; Chen and
Nadziejko 2005; Sun et al. 2005; Sun et al. 2008)o ri n
Manhattan, New York (Ying et al. 2009b). Chen and
Nadziejko (2005) reported that 39–41 week-old apoE
−/−
mice fed a chow diet and exposed to 10X ambient
concentrations of PM2.5 for 6 h per day, 5 days per week
for 5 months led to a 57% increase in the percentage of
atherosclerotic plaque area in the aortic root (Table 2). Sun
et al. (2005) showed that younger 6-week-old apoE
−/− mice
fed a chow diet and exposed to similar conditions for
6 months displayed a 45% increase in the percentage of
aortic atherosclerotic plaque area, which was not statisti-
cally significant however. The feeding of a high-fat diet
resulted in a greater promotion of atherosclerosis that was
statistically significant, as PM2.5-exposed mice displayed a
58% increase in aortic root plaque area (Sun et al. 2005),
together with impaired vasomotor response (Table 2). In
another study, Sun et al. (2008) reported that apoE
−/− mice
fed a high fat diet and exposed to concentrated PM2.5 also
resulted in enhancement of aortic atherosclerosis as
assessed by the percentage of the plaque area in the aortic
arch by ultrasound bio-microscopy. PM2.5 exposures led to
atherosclerotic plaques that were also richer in tissue factor
(Sun et al. 2008), which could play a causative role or
simply be an indicator of greater atherosclerotic plaque
burden. When compared to inhaled side-stream tobacco
smoke, concentrated PM2.5 appears to exert greater promo-
tion of plaque formation as assessed by ultrasound bio-
microscopy (Chen et al. 2010). Importantly, concentrated
PM2.5 from a different location, such as an exposure
laboratory in Manhattan, also resulted in similar proathero-
genic effects (Ying et al. 2009b).
The different degrees how aortic atherosclerosis was
enhanced by PM2.5 in the various CAPs studies can be due
to several factors such as differences in the length of
exposures, the type of experimental diet or the PM
composition. In addition, while 4–6 month exposures to
concentrated PM2.5 in New York (Chen et al. 2010; Chen
and Nadziejko 2005; Sun et al. 2005; Sun et al. 2008; Ying
et al. 2009a) have shown positive results, 5-week exposures
to concentrated PM2.5 in Los Angeles only resulted in a
non-statistically significant trend for increased atherosclerotic
lesions (Araujo et al. 2008), which raises important questions
about toxicological aspects such as effective dose, threshold
or latency of effects. In addition, there have been discrep-
ancies in whether the feeding of cholesterol-enriched diets
and/or extreme hyperlipidemia exert or not an additive effect
to the PM exposures. Thus, two studies have reported a
significant enhancement of atherosclerosis when apoE
-/- mice
were fed a cholesterol-enriched diet (CED) but only
suggestive trends when mice were fed a chow diet (Sun et
al. 2005, 2008). On the other hand, one study showed that
the PM2.5 proatherogenic effects were not seen under the
condition of extreme hyperlipidemia exhibited by apoE
−/−,
LDL-R
−/− mice (Chen and Nadziejko 2005).
Another important aspect relates to the different degree
how PM promotes atherogenesis in different locations
where particulates may originate from different sources,
under different climatological conditions and resulting in
different physicochemical characteristics. Thus, the study
from Ying et al. (2009a) showed that 4-month inhalation
exposures to concentrated PM2.5 in the Upper East side of
Manhattan (6 h/day, 5 days/week) of CED-fed 6-week-old
apoE
−/− mice resulted in ~89% increase in aortic athero-
sclerotic plaques over controls. This is in contrast to the
other CAPs PM2.5 studies where CED-fed mice were
exposed for 5–6 months in Sterling Forest, New York
resulting in an increase from 58% to 68% increase in
atherosclerotic lesions over controls (Sun et al. 2005;
2008). Larger effects with the Manhattan PM2.5 could have
been due to greater PM2.5 levels and/or greater relative
content in organic carbon and elemental carbon as
mentioned by their authors (Ying et al. 2009a).
In relation to the role of particle size, only one study has
approached the question whether particle size has any role
in PM-mediated proatherogenic effects. Thus, Araujo et al.
tested the hypothesis that the smaller size and greater redox
potential of UFP would result in greater proatherogenic
effects than PM2.5 in an animal study at the University of
California in Los Angeles. ApoE
−/− mice were fed a chow
diet and subjected to concentrated PM2.5, UFP or filtered
air for 5 h/day, 3 days per week for 5 weeks. UFP-exposed
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plaques, assessed by the mean atherosclerotic lesional area
in the aortic root, as compared to PM2.5 or FA-exposed
mice, respectively (Araujo et al. 2008), despite an exposure
mass that was ~4 times less. Given that the concentrator
technology employed (Versatile Aerosol Concentration
Enrichment System) in this study generated overlapping
CAPs aerosols, it is difficult to estimate the true relative
proatherogenic strength of UFP vs. PM2.5. While it is
possible that the UFP fraction could concentrate the PM
proatherogenic effects, a clear demonstration of this will
require the straight comparison of UFP to the accumulation
mode particles in the 0.1–2.5 μm range (Araujo and Nel
2009). Interestingly, in this study, UFP exhibited a greater
relative content of PAHs, a whole group of redox-active
compounds that can facilitate free radical reactions (Li et al.
2003; Ntziachristos et al. 2007; Ayres et al. 2008).
Additional studies are required to compare PM2.5 and
UFP exposures in other locations in the world where the
effects of different particle size and composition on
atherosclerosis, can be assessed.
It has been debated whether PM at ambient levels could
cause similar effects to those induced by CAPs over
perhaps longer periods of time. Castro-Soares et al.
addressed this issue by exposing LDL-R
−/− mice to 1X
ambient air (non-filtered) vs. filtered air at a location 20 m
away from the roadside in downtown Sao Paulo, Brazil.
Although mice exposed to non-filtered air developed
atherosclerotic plaques that were comparable in lipid
content to those developed by controls’, their aortic walls
were thicker, suggesting a greater contribution of other
components (either cellular or non-cellular; Soares et al.
2009). Another important point is whether the gasses
could contribute to the vascular proatherogenic effects of
particulates, perhaps by cooperative interactions with them.
There is indeed experimental data that show that gaseous
pollutants could also play a role in promoting atheroscle-
rosis. Lewis et al. showed that exposures of CED-fed
C57BL6 mice to carbon disulfide (CS2), a known volatile
organic compound, at 500 and 800 ppm CS2 6 h/day,
5 days/week for up to 20 weeks, markedly enhanced aortic
atherosclerosis (1999). In addition, Chuang et al. (2009)
reported that apoE
−/− mice exposed to 0.5 ppm O3 for 8 h/
day, 5 days/week for 8 weeks exhibited more than double
the degree of aortic atherosclerosis exhibited by filtered air-
exposed controls (Table 2). Furthermore, Campen et al.
examined the effect of whole vs. particle-filtered diesel
exhausts emissions on atherosclerotic lesion formation of
CED-fed 10-week-old male apoE
−/− mice over 50 days.
Although they did not find significant differences in the
extent of aortic plaque formation between the various
groups, mice exposed to whole diesel exhausts developed
atherosclerotic lesions with greater macrophage content
(Campen et al. 2010; Table 2). Interestingly, exposure to
whole diesel exhausts led to upregulation of MMP-9 in the
aorta, consistent with similar effects reported for gasoline
exhausts (Lund et al. 2007). While particle-filtering tended
to diminish the effects of the diesel emissions on plaque
macrophage content, it did not alter the degree of aortic
MMP-9 upregulation (Campen et al. 2010), suggesting that
both gaseous and particulate components could be affecting
different pathways. It is possible then that gaseous and
particulate pollutants could exert different but cooperative
effects, which will need to be explored in more details in
the future, in spite of a recently published study that did not
find any contribution of diesel exhaust gasses to the effects
exerted by CAPs inhalations (Quan et al. 2010).
Altogether,the reportedliteraturesuggeststhatparticlesize
and chemical composition are important determinants in the
ability of particulates to enhance atherosclerotic lesion
formation. In addition, while the epidemiological data mostly
points towards the contribution of the particulate matter, the
experimental animal data suggests that gaseous components
may also play a role.
How does particulate matter promote atherosclerosis?
PM-enhanced atherosclerosis is most likely the result of
systemic prooxidant and proinflammatory effects. These
systemic effects could derive from increased ROS produc-
tion and development of inflammation in the lungs that
somehow may get transduced to the systemic tissues (e.g.,
release of inflammatory mediators into the blood; pathway
2 of Fig. 1) or they could be the result of translocation of
particles or their chemical constituents into the systemic
circulation with direct action at the target vascular sites
(pathway 3 of Fig. 1). There are multiple reports that
support the ability of PM to induce local prooxidant and
proinflammatory effects in the lungs. The latter may
include activation of inflammatory molecular pathways
without histological evidence of overt pulmonary inflam-
mation, local activation of cells leading to pan-systemic
activation of the adaptive immune system or infiltration of
the lungs by inflammatory cells with the development of
histologically defined pulmonary inflammatory foci
(Fig. 1). This article focuses however on the experimental
evidence that supports the occurrence of those effects in
systemic tissues, especially at the target vessels (summa-
rized in Table 3) as follows:
Systemic oxidative stress Human studies have associated
exposure to PM with increased systemic oxidative stress,
which include the detection of biomarkers of oxidative
alteration of proteins, lipids and/or DNA in the circulating
blood or in products excreted in the urine, as recently
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Mechanisms Indicators References
Evidence in cellular and/or animal studies
Oxidative stress in systemic
tissues
Increased liver peroxidation and upregulation
of antioxidant genes in liver
(Gong et al. 2007; Araujo et al. 2008)
Alteration of circulating
lipoproteins
Oxidative modification of LDL (Soares et al. 2009)
Generation of dysfunctional HDL (Araujo et al. 2008)
Vascular prooxidant effects Increased ROS production in ECs and
macrophages
(Goldsmith et al. 1998; Hiura et al. 1999; Soukup et al. 2000;
Bai et al. 2001; Lee and Kang 2002; Hirano et al. 2003;
Li et al. 2004; Li et al. 2006; Chio et al. 2007; Li et al.
2010; Montiel-Davalos et al. 2010)
Upregulation of antioxidant genes in ECs and
macrophages
(Hirano et al. 2003; Li et al. 2004; Gong et al. 2007;
Li et al. 2010)
Activation of NADPH oxidase in ECs and
macrophages
(Beck-Speier et al. 2005; Li et al. 2006; Mo et al. 2009)
Induction of electron leaks in mitochondrial
electron transport complexes in ECs
(Li et al. 2006)
Increased ROS in vessels with atherosclerotic
plaques
(Sun et al. 2005; Ying et al. 2009a)
Vascular proinflammatory
effects
Greater proinflammatory cytokine production
in ECs and macrophages
(Alfaro-Moreno et al. 2002; Fujii et al. 2002; Jimenez et al.
2002; Amakawa et al. 2003; Osornio-Vargas et al. 2003;
Pozzi et al. 2003; Brown et al. 2004; Becker et al. 2005a;
Ishii et al. 2005; Imrich et al. 2007; Li et al. 2010)
Increased expression of cell adhesion molecules
in ECs
(Li et al. 2010)
Greater monocyte adhesion to ECs (Li et al. 2010)
Monocyte migration and recruitment in
atherosclerotic vessels
(Yatera et al. 2008)
Activation of NF-kB in ECs and macrophages (Mondal et al. 2000; Montiel-Davalos et al. 2010)
Activation of MAPK in ECs and macropages (Hiura et al. 1999; Sumanasekera et al. 2007; Mo et al. 2009)
Activation of ERK1/2 pathways in ECs and
macrophages
(Beck-Speier et al. 2005; Mo et al. 2009)
Increased proinflammatory cytokines in
circulating blood
(Mutlu et al. 2007; Tamagawa et al. 2008)
Vascular toxic effects Decrease in viability of ECs and macrophages (Hiura et al. 1999; Bai et al. 2001; Lee and Kang 2002)
Increased in ECs and macrophages (Hiura et al. 1999; Lee and Kang 2002; Montiel-Davalos
et al. 2010)
Increase in EC permeability and/or upregulation
of genes involved in EC permeability
(Nadadur et al. 2009; Wang et al. 2010)
Antiproliferative effects in ECs (Yamawaki and Iwai 2006)
Evidence in humans Subclinical measures
Systemic inflammation Elevated circulating pro-inflammatory
biomarkers/mediators (figrinogen,
CRP, TNF-α, IL 1-ß, IL-6, IL-7,
GM-CSF, ICAM-1)
(Ibald-Mulli et al. 2001; van Eeden et al. 2001; Pope et al.
2004; Riediker et al. 2004; Analitis et al. 2006; Peters et al.
2006; Zeka et al. 2006; Chuang et al. 2007;O ’Neill et al.
2007; Ruckerl et al. 2007)
Systemic oxidative stress Increased biomarkers of lipid, protein or
DNA oxidation
(Sorensen et al. 2003; Vinzents et al. 2005; Brauner
et al. 2007)
Elevated plasma homocysteine (Baccarelli et al. 2007; Park et al. 2008)
Inhibition of oxidative response by w-3 PUFA (Romieu et al. 2008)
Systemic hypertension Elevated systemic diastolic and/or systolic
blood pressure
(Ibald-Mulli et al. 2001; Lippmann et al. 2003; Choi et al.
2007; Chuang et al. 2007; Diez Roux et al. 2008; Dvonch
et al. 2009; Zanobetti and Schwartz 2009)
Elevated endothelin-1 levels (Peters et al. 2006)
CRP C-reactive protein, ECs endothelial cells, ET-1 endothelin 1, GM-CSF granulocyte macrophage colony-stimulating factor, ICAM-1
intercellular adhesion molecular 1; IL interleulin, PUFA polyunsaturated fatty acids, ROS reactive oxygen species, TNF-α tumor necrosis factor α
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trolled exposure studies, panel and cross-sectional studies,
generally small in size. Measures of oxidation in circulating
blood are highly relevant since they may imply the
involvement of oxidatively modified plasma lipoproteins
such as LDL and/or high-density lipoprotein (HDL), key
players in the promotion or protection from atherosclerosis,
respectively (Araujo and Nel 2009). Liu et al. (2009)
reported the association of increases in exposure to black
carbon and PM2.5 with elevation in plasma levels of
thiobarbituric acid reactive substances (TBARS) of 28
nonsmoking seniors, in agreement with earlier reports of
increased serum TBARS in association with PM2.5 (Sorensen
et al. 2003) or after moving or living in a polluted urban
location such as Mexico city (Medina-Navarro et al. 1997;
Sanchez-Rodriguez et al. 2005).
Experimental animal work brings support to the causality
notion. Indeed, we have reported that exposure to CAPs in
the PM2.5 and UFP size ranges led to increased hepatic lipid
peroxidation, accompanied by a higher upregulation of Nrf2-
regulated antioxidant genes and unfolded protein response
(UPR) genes of UFP-exposed mouse livers (Gong et al.
2007;A r a u j oe ta l .2008). Castro-Soares et al. (2009)h a v e
shown that chronic exposure to urban air pollution led to
enhanced susceptibility of LDL to oxidation in hyperlipemic
LDL-R
−/− mice fed a high fat diet as determined by a
kinetics of LDL oxidation by CuSO4. Interestingly, animals
exposed to polluted air also developed increased plasma
levels of anti-oxidized LDL antibodies (Soares et al. 2009).
Although LDL oxidation has not been demonstrated in any
of the CAPs studies using apoE
−/− mice, we have reported
that 5-week exposures of apoE
−/− mice to concentrated PM
led to the development of dysfunctional HDL (Araujo et al.
2008) as it is discussed below. It is not known how PM
inhalations can modify HDL function but it could likely be
the result of oxidative modifications on either its protein and/
or lipid components that may result in abrogation of its
antioxidant enzymatic activities as well as anti-inflammatory
and reverse cholesterol-transport properties. Thus, PM
prooxidant effects could be enhancing the proatherogenic
properties of LDLs and diminishing the antiatherogenic
properties of protective HDLs.
Vascular prooxidative effects PM has been shown to exert
prooxidative effects in vitro in cell types that are key
players in the development of atherosclerotic lesions such
as endothelial cells (Bai et al. 2001; Hirano et al. 2003;L i
et al. 2006, 2010; Montiel-Davalos et al. 2010), macro-
phages (Goldsmith et al. 1998; Hiura et al. 1999; Soukup et
al. 2000; Lee and Kang 2002; Li et al. 2004; Chio et al.
2007; Ohyama et al. 2007) and possibly smooth muscle
cells (Sun et al. 2008). Indeed, DEP or ambient PM have
been reported to increase ROS production in human aortic
endothelial cells (Li et al. 2010; Montiel-Davalos et al.
2010), likely by activation of the endothelial NADPH
oxidase (Mo et al. 2009) and/or electron leaks in the
mitochondrial electron transport complexes (Li et al. 2006).
It seems that DEP in the ultrafine size range stimulates
superoxide production in human aortic endothelial cells,
partly mediated by JNK activation (Li et al. 2009). PM can
also lead to increased nitric oxide production in pulmonary
artery endothelial cells (Bai et al. 2001). Increased ROS can
lead to the upregulation of antioxidant genes such as HO-1
in human aortic endothelial cells (Li et al. 2010), human
microvascular endothelial cells (Gong et al. 2007) and rat
heart microvessel endothelial cells (Hirano et al. 2003). PM
can exert similar in vitro prooxidant effects in macro-
phages, which has been demonstrated in cultures of
immortalized immune cells such as THP-1 (Hiura et al.
1999; Chio et al. 2007) and RAW264.7 cells (Hiura et al.
1999; Li et al. 2004) or in primary cell cultures of blood
monocytes (Ohyama et al. 2007), thyglycolate-stimulated
peritoneal macrophages (Lee and Kang 2002; Li et al.
2004) or alveolar macrophages (Goldsmith et al. 1998;
Soukup et al. 2000; Beck-Speier et al. 2005). The use of the
latter macrophages could give clues about the effects on
systemic macrophages despite their different localization.
Exposure to PM also results in prooxidant vascular effects
in vivo. Nurkiewicz et al. (2004, 2006)showed in rats that
intratracheal instillation of residual oil fly ash (ROFA) led to
greater vascular ROS generation, as assessed by the
tetranitrobluetetrazolium reduction method (Nurkiewicz et
al. 2006), resulting in a dose-dependent impairment of
systemic endothelium-dependent arterial dilation as well as
proinflammatory effects. Likewise, inhalation exposures to
concentrated PM2.5 has led to enhanced ROS generation in
the aortic plaques, increased formation of 3-nitrotyrosine
residues (Sun et al. 2005;Y i n ge ta l .2009b) and upregula-
tion of the NADPH oxidase subunits p47phox and Rac1
(Ying et al. 2009b).
Systemic inflammation PM exposure has been associated
with increased proinflammatory mediators in the sys-
temic circulation, both in animals (Mutlu et al. 2007;
Tamagawa et al. 2008) and humans (van Eeden et al.
2001). IT administration of ROFA to rats led to increased
leukocyte rolling and adhesion as well as deposition of
myeloperoxidase in the spinotrapezius muscle microcircu-
lation (Nurkiewicz et al. 2004, 2006) together with the
prooxidant effects mentioned above. In New Zealand
White Rabbits and mice, IT PM10 administration resulted
in significantly increased serum IL-6 levels (Mutlu et al.
2007; Tamagawa et al. 2008)a sw e l la sT N F - α (Mutlu et
al. 2007). Interestingly, lack of IL-6 ameliorated the PM10-
mediated systemic proinflammatory response as well as a
PM10 procoagulant state in mice (Mutlu et al. 2007),
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PM systemic inflammatory effects. Likewise, CAPs PM2.5
inhalation exposures led to elevation in circulating IL-6
and TNF-alpha (Sun et al. 2009) together with increases in
circulating adipokines, such as resistin and a change in the
balance of macrophages in adipose tissue towards the
proinflammatory M1 phenotype, suggestive of a systemic
proinflammatory state (Sun et al. 2009). Furthermore, it
has been shown that PM induces increased monocyte
migration to atherosclerotic vessels in Watanabe rabbits
(Yatera et al. 2008). In humans, PM exposures has been
reported to associate with increased blood levels of granulo-
cyte macrophage colony-stimulating factor (GM-CSF), IL-6,
IL-1, sTNF-RII, CRP, and sCD40L (van Eeden et al. 2001;
Dubowsky et al. 2006; Chuang et al. 2007; Ruckerl et al.
2007; Delfino et al. 2008).
We have shown that CAPs exposures led to the
development of dysfunctional HDL in apoE
−/− mice as
mentioned above. Interestingly, the degree of HDL dys-
function was particle size-dependent since UFP exposures
led to a greater degree of dysfunction than did PM2.5
(Araujo et al. 2008). Using a monocyte chemotactic assay
in a co-culture of endothelial cells and smooth muscle cells
that evaluated the HDL anti-inflammatory capacity by
determining the degree of inhibition of LDL-induced
chemotaxis, UFP exposures not only failed to inhibit
LDL-mediated inflammatory effects as PM2.5 exposures
did, but it promoted more monocyte migration. This greater
degree of HDL dysfunction correlated with the greater
degree of atherosclerosis and a systemic Nrf2-regulated
antioxidant response, supporting the notion that dysfunc-
tional HDL could either play a role in disease pathogenesis
or serve as a marker for the PM-mediated systemic
prooxidant and/or proinflammatory effects. Indeed, proin-
flammatory HDL has been reported to predict susceptibility
to atherosclerosis in humans (Ansell et al. 2003) and in
rabbits (Van Lenten et al. 2007) and although there is no
firm evidence yet that greater levels of proinflammatory
HDL do promote atherogenesis, better characterization of
this phenotype would be helpful since it could contribute to
a better understanding of the pathogenesis and/or lead to
the identification of a useful biomarker for the exposures or
PM systemic effects.
Vascular proinflammatory effects In vitro work with endo-
thelial cells in culture has shown that DEP and ambient PM
can lead to the activation of NF-kB (Li et al. 2010; Montiel-
Davalos et al. 2010), p38 MAPK (Sumanasekera et al.
2007; Mo et al. 2009), and ERK1/2 pathways (Mo et al.
2009) with subsequent upregulation of proinflammatory
TNF-α (Li et al. 2010; Montiel-Davalos et al. 2010).
Likewise, treatment of endothelial cells with PM results in
increased expression of cell adhesion molecules such as
VCAM (Li et al. 2010), E-selectin, P-selectin (Montiel-
Davalos et al. 2007) and increased cytokine production such
as IL-8 and monocyte chemotactic protein 1 (Li et al. 2010).
Similar proinflammatory effects occur in PM-treated
macrophages of various sources (Table 3). Both DEP and
ambient PM treatments of either human/rat/mouse alveolar
macrophages, human blood monocytes, THP-1 monocytes,
RAW 264.7 macrophages, and/or J774A macrophages have
been reported to result in increased production of TNF-α,
IL-6 (Alfaro-Moreno et al. 2002; Fujii et al. 2002;
Amakawa et al. 2003; Osornio-Vargas et al. 2003;P o z z ie t
al. 2003;B e c k e re ta l .2005a), IL-8 (Monn and Becker 1999;
Becker et al. 2005b), IL1-α (Brown et al. 2004), IL1-β
(Jimenez et al. 2002), GM-CSF (Fujii et al. 2002; Ishii et al.
2005), and macrophage-inflammatory protein-2 (Imrich et al.
2007). Furthermore, it has been reported that PM induces
greater monocyte adhesion to human aortic endothelial cells
(Li et al. 2010). Interestingly, the ability of DEP in the
ultrafine range generated from a same engine, under an
idling vs. drivingmodeledtoparticleswithdifferentchemical
composition that diverged on their prooxidant vs proinflam-
matory potentials (Li et al. 2010) which indicate that PM
could activate various pathways, not all ROS related.
Vascular cytotoxic effects PM has been shown to exert
toxic effects in endothelial cells (Li et al. 2010; Montiel-
Davalos et al. 2010) and macrophages (Hiura et al. 1999;
Lee and Kang 2002; Table 3). PM can lead to increased
permeability of endothelial cells (Wang et al. 2010), which
could facilitate systemic translocation of particles or their
chemical constituents onto the systemic circulation, release
of inflammatory mediators from the lungs or monocyte
migration to vascular sites. PM toxic effects also lead to
stimulation of apoptosis (Hiura et al. 1999; Lee and Kang
2002; Montiel-Davalos et al. 2010), inhibition of cellular
proliferation (Yamawaki and Iwai 2006) and decreased cell
viability in cultures (Hiura et al. 1999; Bai et al. 2001; Lee
and Kang 2002). Overall, vascular cytotoxicity may have
various effects on atherogenesis that can depend on the stage
ofplaquedevelopment.Forinstance,whileapoptosishasbeen
thought to limit early atherogenesis, it may actually do the
opposite in more advanced lesions (Tabas 2007).
Vascular dysfunction Several studies have reported the
ability of both particulate and gaseous pollutants to cause
vascular dysfunction, both on its constricting ability as well
as its vasodilatory capacity, by mechanisms that could be
either endothelial-dependent (O’Neill et al. 2005; Briet et
al. 2007; Ruckerl et al. 2007; Rundell et al. 2007; Liu et al.
2009) or independent (O’Neill et al. 2005). Accumulating
evidence suggests that endothelial dysfunction could be an
early marker for atherosclerosis (Davignon and Ganz 2004)
but less likely that it could independently increase the
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alteration in vascular reactivity function could be a
consequence of the same PM-induced systemic prooxidant
and proinflammatory effects described above, in addition to
neurohormonal mechanisms (pathway 1 of Fig. 1).
Hypertension Several studies report the association of air
pollutants with hypertension (Ibald-Mulli et al. 2001;
Lippmann et al. 2003; Choi et al. 2007; Chuang et al.
2007; Diez Roux et al. 2008; Dvonch et al. 2009; Zanobetti
and Schwartz 2009; Table 3), a well-known risk factor for
atherosclerosis. Pro-hypertensive and vasoconstrictive
effects appear to occur both in the pulmonary and systemic
circulation and seem to include a variety of mechanisms
thatrange fromincreasedROSgenerationandendothelial cell
dysfunction to neurohormonal activation. The latter may
occur due to increased activity of the sympathetic nervous
system as well as enhanced endothelin 1 and angiotensin II
receptor pathways, all leading to decreased endothelial-
dependent vasodilatation and enhanced vasoconstrictor activ-
ity in several studies. Thus, while some of the systemic
prooxidant and proinflammatory effects mentioned above
could be partially responsible, it is also likely that neurohor-
monal mechanisms could contribute in some degree to those
effects (pathway 1 of Fig. 1; Brook 2008). Indeed, it is
possible that PM-induced hypertension could play a role in
the promotion of atherosclerosis; however, no hypertensive
effects have been reported in any of the atherosclerosis
studies conducted with experimental animals so far.
Altogether, cumulative evidence suggests that PM-induced
systemicprooxidant and proinflammatory effects appear to be
at the center of its ability to enhance atherosclerosis as shown
byseveralstudiesusinginvitroandinvivoapproaches.While
the data from some studies may carry higher significance than
from others, it is the convergence of similar findings from
different experimental designs and approaches what brings
more robustness to this notion. These prooxidant and
proinflammatory effects could be mediated by various path-
ways with various degrees of involvement of the lungs
(Fig. 1). It appears that UFP may exhibit greater ability to
enhance atherosclerosis than larger particulate. Various
reasons that could explained their greater proatherogenic
potential include larger particle number, greater lung
retention, larger content of redox active compounds, and
greater bioavailability as we have recently reviewed in
details (Araujo and Nel 2009).
Effects of particulate matter on vascular gene expression
Several transcriptomic studies have been performed either
in tissues harvested from animals exposed to PM or in cells
treated in culture with PM or their chemical constituents.
The large majority of studies have focused on the PM
effects in the lungs which may help to determine the degree
of pulmonary involvement in the development of systemic
vascular effects. Fewer studies have been performed in
vascular cells, either on endothelial cells (Yamawaki and
Iwai 2006; Gong et al. 2007; Nadadur et al. 2009),
macrophages (Verheyen et al. 2004; Huang et al. 2009)o r
atherosclerotic plaques from exposed mice (Floyd et al.
2009; Table 4), which have provided clues on some of the
molecular pathways that may be responsible for the
phenotypes observed. This article focuses on the latter.
It is interesting how all these studies have shown the
involvement of inflammatory pathway genes in vascular
cells such as chemokin (C-X-C motif) ligand 2 (CXCL2),
CXCL3, IL-8 which confirms both in vitro and experimen-
tal animal studies described in previous sections. Various
antioxidant genes have also been found upregulated in
endothelial cells (Yamawaki and Iwai 2006), macrophages
(Huang et al. 2009; Table 4) and atherosclerotic plaques
(Floyd et al. 2009) such as HO-1, superoxide dismutase 2,
NAD(P)H:quinone oxidoreductase 1, and various metal-
lothioneins, likely in response to the PM-mediated enhance-
ment of ROS in the vasculature. ROS and inflammatory
stressors result in the activation of UPR genes (e.g., activating
factor 3, activating factor 4, and X box-binding protein 1;
XBP1) as we have shown in endothelial cells treated with
DEP (Gong et al. 2007), also found to be upregulated after
treatment with carbon black (Yamawaki and Iwai 2006).
Importantly, the identification of this pathway by an in vitro
transcriptomic approach (Gong et al. 2007) led to the
identification of the involvement of that same pathway in
vivo (Araujo et al. 2008), which underscores the importance
of these approaches in identifying molecular footprints of
relevance.
While the individual contribution of air pollutants to
atherogenesis might be small, we have thought that their
effects could be exacerbated in synergy with other known
proatherogenic factors. We tested this hypothesis by evaluat-
ingtheantioxidantresponseofmicrovascularendothelialcells
to DEP in the absence and presence of oxidized PAPC
(1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine),
one of the key prooxidative components generated in LDL
particles. As both DEP and ox-PAPC led to prooxidative
effects that were expected (Bai et al. 2001; Hirano et al.
2003), the combination of both treatments synergized in
increasing antioxidant gene expression, including HO-1
(Gong et al. 2007). In addition, network analysis of the
genomic profiles of cells subjected to the various treatments
revealed groups of genes enriched in synergistic interactions
between DEP and ox-PAPC leading to activation of several
pathways (e.g., inflammation, apoptosis, unfolded protein
response) of relevance in atherogenesis. Some representative
examples included proinflammatory genes such as IL-8 and
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Air Qual Atmos Health (2011) 4:79–93 89CXCL1 production, immune response genes such as IL-11
and UPR genes such as ATF 4, heat shock 70 kDa protein
8 and XBP1. Here again, the use of a transcriptomic approach
helpedustoidentifycooperativeinteractionsbetweenPMand
oxidized lipids that could also be of importance in the
development of atherosclerotic lesions in vivo.
Conclusions and perspectives
Exposure to air pollution leads to increased cardiovascular
morbidity and mortality, predominantly of ischemic nature.
Epidemiological studies show there is a positive association
betweenexposureto PM and measuresof atherosclerosis, that
is likely to be causal as supported by animal studies. PM-
mediated enhancement of atherosclerosis is likely to be the
result of its systemic prooxidant and proinflammatory effects.
It will be important to dissect the mechanisms for the
development of vascular systemic effects and to determine
whether the lungs play an active role. Effects on circulating
lipoproteins need to be characterized in details and
confirmed in humans, since they may yield a better
understanding of the PM-mediated pathogenesis and could
lead to the identification of a biomarker of exposures and/or
development of PM systemic effects. Likewise, there is
need of epidemiological and exposure studies to evaluate
UFP toxicity in humans. Transcriptomic and proteomic
studies in cells and/or tissues harvested from animals or
subjects exposed to air pollutants are highly promising tools
to give clues on the molecular pathways involved. Genomic
studies are also required to unravel gene–environment
interactions of importance and to identify profiles that
could result in increased genetic susceptibility to air
pollution-mediated CV effects.
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